Phase Genomics Raises $1.5M Funding

Phase Genomics, a Seattle, WA-based genomics technology development company, raised $1.5M in funding.

Bill & Melinda Gates Foundation provided the funding.

The company intends to use the funds to develop a new antimicrobial discovery platform.

Led by Ivan Liachko, PhD, Founder and CEO, Phase Genomics applies proprietary proximity ligation technology to enable chromosome-scale genome assembly, microbiome discovery, as well as analysis of genomic variation and genome architecture. In addition to a comprehensive portfolio of laboratory and computational services and products, including kits for plants, animals, microbes, and human samples, they also offer a genome and metagenome assembly and analysis software.

Commenting on the news, Ivan Liachko said: “Our work at the frontier of microbiome research has unlocked a wealth of new insights on phages, the viruses that infect bacteria. Now, with support from the Gates Foundation, we’re harnessing our global phage database with the goal of improving human and environmental health and providing a critical alternative to traditional antibiotics.